Per Jane McLelland, some clinical teams are concerned that 5 medications (atovaquone, metformin, doxycycline, niclosamide, and ivermectin), when used to destroy cancer cells, may also harm healthy cells - but has been proven to be untrue. They do not harm healthy cells.
These five drugs (atovaquone, metformin, doxycycline, niclosamide, and ivermectin) have an extensive, documented human safety record at doses where its anti-cancer mechanism operates. These medications selectively target cancer stem cells (through their metabolic inflexibility) while not targeting normal cells (due to their metabolic flexibility). There is solid evidence that the concern that “we don’t know if it harms healthy cells” is not true - yet not all clinical teams are aware of this.
Not all clinical teams are aware of cancer’s metabolic inflexibility weakness and that we no longer need to use a treatment that defaults to systemic toxicity as the primary mode of cancer treatment. There is currently a gap between what families deserve to know and what they are told.
The approach outlined in Jane’s How to Starve Cancer book has resonated with people who think, correctly, that there was a body of evidence that was not being brought to them.
Jane McLelland continues to push oncologists to look further and deeper.
(In her substack, Jane provides links to 11 studies that prove the safety of these 5 medications.)